ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      56,545.44
      -0.18%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. uniQure NV (QURE)

      7. uniQure NV (QURE) News

      QURE

      uniQure NV (QURE)

      uniQure NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:QURE
      DateTimeSourceHeadlineSymbolCompany
      12/13/20223:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/10/202210:00AMPR Newswire (US)CSL's Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B at 24-Months Post-TreatmentNASDAQ:QUREuniQure NV
      12/01/202210:05PMTipRanksSVB Securities Remains a Buy on uniQure (QURE)NASDAQ:QUREuniQure NV
      12/01/20224:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      12/01/20226:20AMTipRanksAnalysts Are Bullish on Top Healthcare Stocks: uniQure (QURE), Aclaris Therapeutics (ACRS)NASDAQ:QUREuniQure NV
      11/29/202211:00AMGlobeNewswire Inc.uniQure Highlights Therapeutic Potential of AMT-260 in Refractory Temporal Lobe Epilepsy (rTLE) at Virtual Research & Development EventNASDAQ:QUREuniQure NV
      11/25/20228:45PMTipRanksuniQure (QURE) Gets a Buy from RBC CapitalNASDAQ:QUREuniQure NV
      11/25/20224:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      11/25/20224:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      11/25/20224:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      11/25/20224:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      11/25/20226:20AMTipRanksAnalysts’ Top Healthcare Picks: uniQure (QURE), Cidara Therapeutics (CDTX)NASDAQ:QUREuniQure NV
      11/25/20226:05AMTipRanksuniQure (QURE) Gets a Buy from SVB SecuritiesNASDAQ:QUREuniQure NV
      11/23/20229:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:QUREuniQure NV
      11/23/20229:00AMTipRanksQURE: The Most Expensive Treatment EVER Is HereNASDAQ:QUREuniQure NV
      11/22/20224:40PMGlobeNewswire Inc.uniQure announces FDA approval of first gene therapy for adults with hemophilia BNASDAQ:QUREuniQure NV
      11/22/20223:59PMPR Newswire (US)U.S. Food and Drug Administration approves CSL's HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia BNASDAQ:QUREuniQure NV
      11/18/20228:45PMTipRanksuniQure (QURE) Gets a Buy from RBC CapitalNASDAQ:QUREuniQure NV
      11/17/20227:05AMGlobeNewswire Inc.uniQure to Host Virtual Research & Development Event on Tuesday, November 29, 2022NASDAQ:QUREuniQure NV
      11/04/20229:46PMTipRanksRBC Capital Remains a Buy on uniQure (QURE)NASDAQ:QUREuniQure NV
      11/04/20221:45AMTipRanksuniQure (QURE) Receives a Buy from BTIGNASDAQ:QUREuniQure NV
      11/04/20221:20AMTipRanksAnalysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), McKesson (MCK) and uniQure (QURE)NASDAQ:QUREuniQure NV
      11/03/20226:15AMTipRanksH.C. Wainwright Sticks to Its Buy Rating for uniQure (QURE)NASDAQ:QUREuniQure NV
      11/02/20227:47AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:QUREuniQure NV
      11/02/20227:05AMGlobeNewswire Inc.uniQure Announces Third Quarter 2022 Financial Results and Highlights Recent Company ProgressNASDAQ:QUREuniQure NV
      10/11/20227:05AMGlobeNewswire Inc.uniQure Announces Multiple Presentations at the Upcoming Annual Meeting of The European Society of Gene and Cell Therapy (ESGCT)NASDAQ:QUREuniQure NV
      10/03/20227:05AMGlobeNewswire Inc.uniQure to Participate in Upcoming Industry Conferences in OctoberNASDAQ:QUREuniQure NV
      09/26/20224:17PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:QUREuniQure NV
      09/23/20224:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:QUREuniQure NV
      09/06/20227:05AMGlobeNewswire Inc.uniQure to Participate in Upcoming Industry Conferences in SeptemberNASDAQ:QUREuniQure NV
       Showing the most relevant articles for your search:NASDAQ:QURE